Inducer microRNAs in the glioma development: a concise review of mechanisms and insights into targeted therapy

Area of Science:

• Neuro-oncology
• Molecular Biology
• Cancer Research

Background:

• Gliomas are aggressive central nervous system (CNS) cancers with limited treatment options.
• Current therapies like surgery, radiotherapy, and chemotherapy often face challenges such as side effects, recurrence, and resistance.
• Novel therapeutic targets are crucial for improving glioma management.

Purpose of the Study:

• To comprehensively review the role of microRNAs (miRNAs) in glioma development.
• To identify specific miRNAs with potential as therapeutic targets for glioma.
• To explore the association between miRNAs and glioma staging and treatment response.

Main Methods:

• Literature review of studies investigating microRNAs in glioma.
• Analysis of the regulatory functions of miRNAs in cancer cell proliferation and growth inhibition.
• Identification of specific miRNA inducers with potential therapeutic applications in glioma.

Main Results:

• MicroRNAs play diverse and critical roles in cellular processes relevant to cancer.
• Six specific microRNAs (miR-363-3P, miR720, miR-484, miR-890, miR-496, and miR-939-5p) have been identified as potential inducers in glioma cells.
• Various miRNAs are associated with glioma staging and response to anticancer therapy.

Conclusions:

• MicroRNAs represent a promising avenue for novel glioma therapeutic strategies.
• Targeting specific miRNAs could offer new perspectives for managing glioma.
• Further research into miRNA-based therapies is warranted for improved glioma treatment outcomes.